i like this stock,but any bio that says it is trying to fight cancer are some what shady. i think the numbers are good but there is always a chances that it is a house of cards.
and i think it is going up there debt will get knocked out on this deal. earnings should go up based on this deal. will follow and buy more if this is true? good luck, buying
this is a risky stock but hold on there is a need for the drug and adding 1 bil to the balance sheet will push this stock higher. and try buying spy instead. if all eggs are in one basket.